Browse drugs

…minantly stereotactic radiosurgery (SRS)) followed by continued osimertinib, with encouraging PFS/OS and acceptable toxicity. By contrast, …

…ring may help identify patients who could benefit from extended osimertinib therapy, although further clinical validation is warranted.ctDN…

… high-affinity FDA-approved inhibitors for IL6R and EGFR (e.g., tocilizumab and erlotinib), as well as PAM analogs targeting mGluR7. Logic …

… patients. High-risk patients exhibited enhanced sensitivity to dasatinib, docetaxel, erlotinib, and gefitinib ( figure 1).Conclusions Th…

…suggesting that DC inclusion dampens the macrophage response to bemcentinib.9 Separation of macrophages by A375 state was further reflected…

…s of cardiac adverse events. Among third generation inhibitors, osimertinib (2.53, 1.53 to 4.19; high certainty; 8.9%) and lazertinib (2.84…